Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Differential effects of rapamycin on glucose metabolism in 9 inbred strains.

Reifsnyder PC, Te A, Harrison DE.

J Gerontol A Biol Sci Med Sci. 2019 Jul 4. pii: glz157. doi: 10.1093/gerona/glz157. [Epub ahead of print]

PMID:
31276577
2.

Cardioprotective effects of dietary rapamycin on adult female C57BLKS/J-Leprdb mice.

Reifsnyder PC, Ryzhov S, Flurkey K, Anunciado-Koza RP, Mills I, Harrison DE, Koza RA.

Ann N Y Acad Sci. 2018 Apr;1418(1):106-117. doi: 10.1111/nyas.13557. Epub 2018 Jan 29.

3.

Rapamycin treatment benefits glucose metabolism in mouse models of type 2 diabetes.

Reifsnyder PC, Flurkey K, Te A, Harrison DE.

Aging (Albany NY). 2016 Nov 30;8(11):3120-3130. doi: 10.18632/aging.101117.

4.

Rapamycin ameliorates nephropathy despite elevating hyperglycemia in a polygenic mouse model of type 2 diabetes, NONcNZO10/LtJ.

Reifsnyder PC, Doty R, Harrison DE.

PLoS One. 2014 Dec 4;9(12):e114324. doi: 10.1371/journal.pone.0114324. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0119748.

5.

Comparison of Two New Mouse Models of Polygenic Type 2 Diabetes at the Jackson Laboratory, NONcNZO10Lt/J and TALLYHO/JngJ.

Leiter EH, Strobel M, O'Neill A, Schultz D, Schile A, Reifsnyder PC.

J Diabetes Res. 2013;2013:165327. doi: 10.1155/2013/165327. Epub 2013 Apr 8.

6.

Testing the role of P2X7 receptors in the development of type 1 diabetes in nonobese diabetic mice.

Chen YG, Scheuplein F, Driver JP, Hewes AA, Reifsnyder PC, Leiter EH, Serreze DV.

J Immunol. 2011 Apr 1;186(7):4278-84. doi: 10.4049/jimmunol.1003733. Epub 2011 Feb 25.

7.

Diet-induced obesity in two C57BL/6 substrains with intact or mutant nicotinamide nucleotide transhydrogenase (Nnt) gene.

Nicholson A, Reifsnyder PC, Malcolm RD, Lucas CA, MacGregor GR, Zhang W, Leiter EH.

Obesity (Silver Spring). 2010 Oct;18(10):1902-5. doi: 10.1038/oby.2009.477. Epub 2010 Jan 7.

8.

NOD x 129.H2(g7) backcross delineates 129S1/SvImJ-derived genomic regions modulating type 1 diabetes development in mice.

Leiter EH, Reifsnyder PC, Wallace R, Li R, King B, Churchill GC.

Diabetes. 2009 Jul;58(7):1700-3. doi: 10.2337/db09-0120. Epub 2009 Mar 31.

9.

Adipokine and insulin profiles distinguish diabetogenic and non-diabetogenic obesities in mice.

Leiter EH, Reifsnyder PC, Xiao Q, Mistry J.

Obesity (Silver Spring). 2007 Aug;15(8):1961-8.

10.

Targeted disruption of CD38 accelerates autoimmune diabetes in NOD/Lt mice by enhancing autoimmunity in an ADP-ribosyltransferase 2-dependent fashion.

Chen J, Chen YG, Reifsnyder PC, Schott WH, Lee CH, Osborne M, Scheuplein F, Haag F, Koch-Nolte F, Serreze DV, Leiter EH.

J Immunol. 2006 Apr 15;176(8):4590-9.

11.

Novel leptin receptor mutation in NOD/LtJ mice suppresses type 1 diabetes progression: II. Immunologic analysis.

Lee CH, Chen YG, Chen J, Reifsnyder PC, Serreze DV, Clare-Salzler M, Rodriguez M, Wasserfall C, Atkinson MA, Leiter EH.

Diabetes. 2006 Jan;55(1):171-8.

12.

"Agouti NOD": identification of a CBA-derived Idd locus on Chromosome 7 and its use for chimera production with NOD embryonic stem cells.

Chen J, Reifsnyder PC, Scheuplein F, Schott WH, Mileikovsky M, Soodeen-Karamath S, Nagy A, Dosch MH, Ellis J, Koch-Nolte F, Leiter EH.

Mamm Genome. 2005 Oct;16(10):775-83. Epub 2005 Oct 29.

PMID:
16261419
13.

Differential endocrine responses to rosiglitazone therapy in new mouse models of type 2 diabetes.

Leiter EH, Reifsnyder PC, Zhang W, Pan HJ, Xiao Q, Mistry J.

Endocrinology. 2006 Feb;147(2):919-26. Epub 2005 Oct 27.

PMID:
16254032
14.

Novel leptin receptor mutation in NOD/LtJ mice suppresses type 1 diabetes progression: I. Pathophysiological analysis.

Lee CH, Reifsnyder PC, Naggert JK, Wasserfall C, Atkinson MA, Chen J, Leiter EH.

Diabetes. 2005 Sep;54(9):2525-32.

15.

Conditioning the genome identifies additional diabetes resistance loci in Type I diabetes resistant NOR/Lt mice.

Reifsnyder PC, Li R, Silveira PA, Churchill G, Serreze DV, Leiter EH.

Genes Immun. 2005 Sep;6(6):528-38. Erratum in: Genes Immun. 2006 Mar;7(2):184.

PMID:
16015371
16.

Contributions of dysregulated energy metabolism to type 2 diabetes development in NZO/H1Lt mice with polygenic obesity.

Koza RA, Flurkey K, Graunke DM, Braun C, Pan HJ, Reifsnyder PC, Kozak LP, Leiter EH.

Metabolism. 2004 Jun;53(6):799-808.

PMID:
15164332
17.

Differential levels of diabetogenic stress in two new mouse models of obesity and type 2 diabetes.

Leiter EH, Reifsnyder PC.

Diabetes. 2004 Feb;53 Suppl 1:S4-11. Review.

18.

Caspase-1 is not required for type 1 diabetes in the NOD mouse.

Schott WH, Haskell BD, Tse HM, Milton MJ, Piganelli JD, Choisy-Rossi CM, Reifsnyder PC, Chervonsky AV, Leiter EH.

Diabetes. 2004 Jan;53(1):99-104.

19.

Deconstructing and reconstructing obesity-induced diabetes (diabesity) in mice.

Reifsnyder PC, Leiter EH.

Diabetes. 2002 Mar;51(3):825-32.

20.

Maternal environment and genotype interact to establish diabesity in mice.

Reifsnyder PC, Churchill G, Leiter EH.

Genome Res. 2000 Oct;10(10):1568-78.

21.

Genotypic and phenotypic characterization of six new recombinant congenic strains derived from NOD/Shi and CBA/J genomes.

Reifsnyder PC, Flynn JC, Gavin AL, Simone EA, Sharp JJ, Herberg L, Leiter EH.

Mamm Genome. 1999 Feb;10(2):161-7.

PMID:
9922397
22.

NIDDM genes in mice: deleterious synergism by both parental genomes contributes to diabetogenic thresholds.

Leiter EH, Reifsnyder PC, Flurkey K, Partke HJ, Junger E, Herberg L.

Diabetes. 1998 Aug;47(8):1287-95.

PMID:
9703330
23.

B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice.

Serreze DV, Chapman HD, Varnum DS, Hanson MS, Reifsnyder PC, Richard SD, Fleming SA, Leiter EH, Shultz LD.

J Exp Med. 1996 Nov 1;184(5):2049-53.

24.

Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene.

Serreze DV, Prochazka M, Reifsnyder PC, Bridgett MM, Leiter EH.

J Exp Med. 1994 Oct 1;180(4):1553-8.

25.

Typing recombinant inbred mouse strains for microsatellite markers.

Taylor BA, Reifsnyder PC.

Mamm Genome. 1993;4(5):239-42.

PMID:
8507976
26.

Linkage of the thyroid peroxidase locus (Tpo) to markers in the proximal part of chromosome 12 of the mouse.

Taylor BA, Reifsnyder PC, DiLauro R.

Cytogenet Cell Genet. 1992;60(3-4):250-1. No abstract available.

PMID:
1354596

Supplemental Content

Loading ...
Support Center